Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Ansheles

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Terapevticheskii Arkhiv|May 17, 2019
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high riskI V Sergienko, A A Ansheles, О М Drapkina, et al.
Kardiologiia|March 8, 2025
[Transthyretin Amyloid Cardiomyopathy as the Cause of Aortic Stenosis]M V Ezhikova, S N Nasonova, I V Zhirov, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report]F I Orlov, A A Ansheles, S N Nasonova, et al.
Terapevticheskii Arkhiv|August 6, 2024
[Improvement of the technique of positioning the endocardial electrodes of the cardiac contractility modulation device in patients with CHF with reduced ejection fraction and atrial fibrillation]A A Safiullina, T M Uskach, O V Sapelnikov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)]S N Tereshchenko, I V Zhirov, O M Moiseeva, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Terapevticheskii Arkhiv|May 17, 2019
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high riskI V Sergienko, A A Ansheles, О М Drapkina, et al.
Kardiologiia|March 8, 2025
[Transthyretin Amyloid Cardiomyopathy as the Cause of Aortic Stenosis]M V Ezhikova, S N Nasonova, I V Zhirov, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report]F I Orlov, A A Ansheles, S N Nasonova, et al.
Terapevticheskii Arkhiv|August 6, 2024
[Improvement of the technique of positioning the endocardial electrodes of the cardiac contractility modulation device in patients with CHF with reduced ejection fraction and atrial fibrillation]A A Safiullina, T M Uskach, O V Sapelnikov, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)]S N Tereshchenko, I V Zhirov, O M Moiseeva, et al.
Pageof 3